Table 2.
Overdose patients n (%) |
Controls n (%) |
|
Number of patients | 552 | 11 040 |
Type of opioid overdose | ||
Heroin | 14 (2.5) | n/a |
Methadone | 43 (7.8) | n/a |
Synthetic opioids* | 42 (7.6) | n/a |
Other opioids† | 337 (61.1) | n/a |
Unspecified/other opioids | 143 (25.9) | n/a |
Sex | ||
Female | 332 (60.1) | 6640 (60.1) |
Male | 220 (39.9) | 4400 (39.9) |
Age (years) | ||
19–29 | 14 (2.5) | 269 (2.4) |
30–39 | 41 (7.4) | 829 (7.5) |
40–49 | 89 (16.1) | 1771 (16.0) |
50–59 | 165 (29.9) | 3296 (29.9) |
60–69 | 129 (23.4) | 2562 (23.2) |
70–79 | 81 (14.7) | 1611 (14.6) |
80–89 | 25 (4.5) | 561 (5.1) |
≥90 | 8 (1.4) | 141 (1.3) |
Low income | 141 (25.5) | 2607 (23.6) |
Rural residence | 95 (17.2) | 1807 (16.4) |
Substance use disorders‡ | ||
Opioids | 58 (10.5) | 81 (0.7) |
Sedatives and hypnotics | 14 (2.5) | 16 (0.1) |
Stimulants | 17 (3.1) | 31 (0.3) |
Other | 103 (18.7) | 284 (2.6) |
Romano comorbidity score‡ | ||
0 | 202 (36.6) | 6038 (54.7) |
1–2 | 219 (39.7) | 3826 (34.7) |
≥3 | 131 (23.7) | 1176 (10.7) |
Other medical history‡ | ||
Psychiatric illness | 300 (54.3) | 2534 (23.0) |
Pneumonia | 93 (16.8) | 405 (3.7) |
Other respiratory illness | 162 (29.3) | 1709 (15.5) |
HIV | <5 | 56 (0.5) |
Hepatitis C | 15 (2.7) | 27 (0.2) |
Cancer | 52 (9.4) | 822 (7.4) |
Opioid prescription history§ | ||
Methadone | 7 (1.3) | 20 (0.2) |
Buprenorphine/naloxone | <5 | <5 |
High-dose opioid for pain | 305 (55.3) | 2152 (19.5) |
Duration of prescription opioid use (years) | ||
<1 | 61 (11.1) | 1876 (17.0) |
1 to <2 | 92 (16.7) | 2362 (21.4) |
2 to <3 | 53 (9.6) | 1422 (12.9) |
3 to <4 | 47 (8.5) | 1006 (9.1) |
4 to <5 | 33 (6.0) | 797 (7.2) |
≥5 | 266 (48.2) | 3577 (32.4) |
Other prescription history§ | ||
Sedatives and hypnotics | 219 (39.7) | 2506 (22.7) |
Stimulants | 10 (1.8) | 146 (1.3) |
Types of opioid overdose correspond to ICD-10 T40.0-T40.4 and T40.6.
*Includes buprenorphine, fentanyl, pethidine and tramadol.
†Includes codeine, hydromorphone, morphine and oxycodone.
‡Based on diagnoses at a physician or hospital visit in the 365 days before follow-up.
§Based on dispensings in the 180 days prior to follow-up. High-dose opioid use is defined by a dispensing of opioid pain medication of >90 oral morphine equivalents per day. Small cell sizes are denoted as '<5' or 0 as applicable.